CFS/ME and FM diagnoses in sarcoidosis patients (and pre- and post sarcoid)

[richie]

I tried to closely question Copilot AI on the problems of diagnosing sarcoid fatigue as CFS/ME and sarcoid pain as FM. This is what it came up with. I don't think it is bad, though in terms of coping CFS or FM clinics might help some sarcoid patients. It starts with PEM as the ME/CFS cardinal symptom. NB the fatigue of sarcoid does not track granulomatous inflammation in many , many cases.

• PEM is not cleanly defined, and sarcoidosis can produce PEM‑like crashes.
• Granulomas are not the whole of sarcoid biology, so “no granulomas = not sarcoid” is false.
• A sarcoid patient can meet ME criteria, but the criteria were not designed to exclude sarcoid biology.
• Prodromal fatigue and pain in sarcoidosis are documented, and they blur the boundary with ME/FM‑like states.

The only way to resolve the circularity is to separate symptom‑level overlap, mechanistic overlap, and diagnostic logic, because they do not map onto each other.

1. PEM in sarcoidosis vs PEM/PENE in ME​

PEM is the most misused term in this entire field. Three things are true at once:

• Active sarcoidosis can produce profound post‑exertional worsening (fatigue, dyspnoea, pain, cognitive fog).
• ME’s PEM/PENE is defined by a specific pattern of delayed, multi‑system crash, but the definition is inconsistent across criteria.
• The 2‑day CPET signature (VO₂peak drop, anaerobic threshold shift) is so far only documented in ME/CFS, not in sarcoidosis.

This means:

• PEM‑like symptoms do not diagnose ME.
• PEM‑like symptoms do not exclude sarcoidosis.
• Only the 2‑day CPET physiology is unique, but it is not widely used and has not been tested in sarcoid cohorts.

So your point stands: PEM alone cannot separate ME from sarcoidosis, because sarcoidosis produces PEM‑like crashes through inflammation, hypoxia, autonomic dysfunction, and immune activation.

The only thing that remains unique to ME is the specific metabolic/physiologic signature, not the subjective crash.

2. Why a sarcoid patient can meet ME criteria but still not have ME​

This is the core of your circularity problem.

ME criteria assume:

• no active inflammatory disease
• no granulomatous disease
• no systemic immune disorder explaining symptoms

Sarcoidosis violates all three assumptions.

Therefore:

• A sarcoid patient can meet ME criteria on symptoms.
• But the criteria were not designed to distinguish sarcoid immune persistence from ME immune persistence.
• So meeting ME criteria does not imply the patient has ME.

This is not a flaw in the patient; it is a flaw in the criteria.

The only way to break the circularity is to anchor diagnosis in mechanism, not symptoms:

• ME: post‑infectious neuroimmune dysfunction without structural inflammation.
• Sarcoidosis: immune persistence with granulomatous and non‑granulomatous inflammation.

Symptoms overlap; mechanisms do not.

3. FM‑like pain in sarcoidosis​

Fibromyalgia criteria also fail in sarcoidosis because:

• sarcoid small‑fiber neuropathy
• sarcoid myopathy
• steroid myopathy
• chronic immune activation
• autonomic dysfunction

…can all produce widespread pain, sensory amplification, sleep disturbance, and cognitive fog.

So again:

• A sarcoid patient can meet FM criteria.
• But FM criteria do not exclude immune‑driven pain.
• FM is defined as non‑inflammatory, but sarcoid pain can be immune‑activated without being inflammatory in the classical sense.

Your point is correct: immune activation ≠ inflammation, and FM criteria do not account for immune activation.

4. Prodromal fatigue and pain before sarcoidosis diagnosis​

This is documented.

Large registry studies (Sweden, Denmark, US VA cohorts) show that patients who later develop sarcoidosis have years of increased healthcare use for:

• unexplained fatigue
• musculoskeletal pain
• malaise
• low‑grade inflammatory symptoms
• sleep disturbance
• depression
• dyspnoea without radiographic findings

This supports your argument:

• There is a pre‑granulomatous immune‑persistence phase.
• It produces fatigue and pain that resemble ME/FM‑like states.
• It is not caused by granulomas.
• It is not captured by ME or FM criteria.
• It blurs the boundary between “ME‑like” and “early sarcoid”.

This is exactly where the BTN2A2/BTNL2 parallel becomes meaningful: both represent T‑cell braking failure, but sarcoidosis has the granuloma module and ME does not.

5. Why the diagnostic boundaries fail​

You’ve identified the real problem:

• PEM is not specific.
• FM pain is not specific.
• Sarcoidosis has immune‑persistence phases that mimic both.
• ME and FM criteria were not designed to exclude sarcoid biology.
• Sarcoidosis is not only granulomas, so “no granulomas = not sarcoid” is false.
• 2‑day CPET is the only unique discriminator, but it is not validated in sarcoidosis.

So the circularity is not in your reasoning; it is in the diagnostic frameworks.

6. The clean resolution​

The only non‑circular way to separate these conditions is:

Mechanism‑based​

• ME: post‑infectious neuroimmune dysfunction without structural inflammation.
• Sarcoidosis: immune persistence with granulomatous and non‑granulomatous inflammation.
• FM: central pain amplification without structural inflammation, but immune activation can coexist.

Biomarker‑based​

• Sarcoidosis: ACE, sIL‑2R, imaging, biopsy, organ involvement.
• ME: no structural markers; only physiologic signatures (2‑day CPET).
• FM: no structural markers; diagnosis of exclusion.

Symptom‑based​

Not reliable for separation.

7. The key insight​

A sarcoid patient with immune‑persistence biology can fit ME criteria, but that does not mean they have ME. It means the criteria are not designed for diseases with immune‑persistence phases.

A sarcoid patient with widespread pain can fit FM criteria, but that does not mean they have FM. It means FM criteria do not account for immune‑activated pain.

A sarcoid patient with fatigue and pain can have a prodrome, not ME or FM.

One question to move this forward​

Are you trying to build a non‑circular diagnostic framework for distinguishing:

• ME
• FM
• active sarcoidosis
• post‑sarcoidosis immune persistence
• sarcoid prodrome

…in patients who present with fatigue, pain, and PEM‑like crashes?

If so, I can map the mechanisms, symptoms, and biomarkers into a single integrated diagnostic matrix.

 

[Clio]

I am not really attached to the ME/CFS label, I just want to be healthy again like everyone.

But so far every "actually it's not ME/CFS it's X" has been very disappointing.

It's Lyme! Okay what's the treatment then? Several months of IV antibiotics just to be as sick? Oh.

It's UARS! Okay what's the treatment then? Surely a CPAP/BIPAP/whateverPAP? No? Oh.

It's sarcoidosis! What's the treatment? Fill in the blank as I do not know but at this point I am sceptical of ever feeling well again...

 

[richie]

I am not really attached to the ME/CFS label, I just want to be healthy again like everyone.

But so far every "actually it's not ME/CFS it's X" has been very disappointing.

It's Lyme! Okay what's the treatment then? Several months of IV antibiotics just to be as sick? Oh.

It's UARS! Okay what's the treatment then? Surely a CPAP/BIPAP/whateverPAP? No? Oh.

It's sarcoidosis! What's the treatment? Fill in the blank as I do not know but at this point I am sceptical of ever feeling well again...

My position is similar except that I have had a sarcoid diagnosis since 2021 and fair suspicion of Lyme exposure. 1985-05 I had nothing to even guess at. YOu have my sympathy.

 

[Jonathan Edwards]

The only way to resolve the circularity is to separate symptom‑level overlap, mechanistic overlap, and diagnostic logic, because they do not map onto each other.

That is a neat way of putting things.
But we don't have a mechanistic story for ME/CFS so I don't think there is a solution of the sort being suggested. To me the solution is the caveat in ME/CFS diagnosis that the symptoms cannot be explained by some co-existing (partially) understood disease mechanism.

 

[richie]

That is a neat way of putting things.
But we don't have a mechanistic story for ME/CFS so I don't think there is a solution of the sort being suggested. To me the solution is the caveat in ME/CFS diagnosis that the symptoms cannot be explained by some co-existing (partially) understood disease mechanism.

The 1M word is "partially" since it is the unexplained part of sarcoid fatigue and pain which leads to the CFS/ME and FM diagnoses. My take is that symptomatic overlap and possible coping stategies and even medications alongside common patien experience may make a CFS/ME or FM diagnoses helpful, and that could easily be explained to patients without the pretence that the symptoms have nothing to do with sarcoid. What happens is that many patients come away thinking they have been given an alternative explanation for their symptoms.

Sarcoid medics when they diagnose CFS/ME in sarkies are either implying that they know there is no causal association between sarcoid and such symptoms or that the underlying biology of such symptoms and ME/CFS is the same (speculative at best) or that biology is unimportant and symptoms are all there is a la BPS, which is unfounded in terms of sarcoid and contrary to the opinions of a growing number of experts in CFS/ME. On this basis the sarc world can take their eyes off the ball terms of elucidating why these symptoms occur so often in sarcoid while tacitly passing comment on the aetiology of CFS/ME, in which they have no training nor expertise. It's wrong. But if simply presented as "We can do no more in this clinic because we do not yet understand why these symptoms occur in sarcoid (and before and after), they might be able to help you in CFS clinic (or FM) along with the explicit allowance that the symptoms in sarcoid may well be rooted in poorly understood aspects of sarcoid , that would be better. What really is needed is a paradigm shift away from sole consideration of granulomas to the immune system that produces them and shows signs of disorder before (up to 27yrs in a Swedish study) and after them.

There may be important bio overlaps and I do wonder if rapamycin might help sarcoid and ME/CFS.